Blueprint Medicines Corp (BPMC)

59.69 -0.70  -1.16% NASDAQ Apr 3, 20:00 Delayed 2m USD

Blueprint Medicines EPS Diluted from Continuing Operations (Quarterly)

View 4,000+ financial data types
Browse...

Historical EPS Diluted from Continuing Operations (Quarterly) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 Upgrade
Sept. 30, 2019 Upgrade
June 30, 2019 Upgrade
March 31, 2019 Upgrade
Dec. 31, 2018 Upgrade
Sept. 30, 2018 Upgrade
June 30, 2018 Upgrade
March 31, 2018 Upgrade
Dec. 31, 2017 Upgrade
Sept. 30, 2017 Upgrade
   
June 30, 2017 Upgrade
March 31, 2017 Upgrade
Dec. 31, 2016 Upgrade
Sept. 30, 2016 Upgrade
June 30, 2016 Upgrade
March 31, 2016 Upgrade
Dec. 31, 2015 Upgrade
Sept. 30, 2015 Upgrade
June 30, 2015 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View EPS Diluted from Continuing Operations (Quarterly) for BPMC

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

Benchmarks
Adaptive Biotechnologies Corp Upgrade
Biomarin Pharmaceutical Inc Upgrade
Emergent BioSolutions Inc Upgrade

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

Minimum Upgrade Jun 2019
Maximum Upgrade Sep 2015
Average Upgrade

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.